Abbott Laboratories

NYSE-ABT

Assets	Sep '25	Jun '25	Mar '25	Dec '24	Sep '24	Jun '24
Cash and Cash Equivalents	7,511	6,951	6,532	7,616	7,558	6,987
Cash and Cash Equivalents
Short-Term Investments	222	331	312	351	230	232
Short-Term Investments
Total Cash and Cash Equivalents	7,733	7,282	6,844	7,967	7,788	7,219
Accounts Receivable	8,138	7,972	7,327	6,925	7,051	6,854
Trade Receivables, Net
Other Receivables	2,260	2,260	2,343	2,570	2,150	2,232
Other Prepaid Expenses and Receivables
Prepaid Expenses and Other Receivables
Total Trade Receivables	10,398	10,232	9,670	9,495	9,201	9,086
Inventories	6,708	6,954	6,639	6,194	6,813	6,814
Finished Products
Work in Process
Materials
Other Current Assets	2,260	2,260	2,343	2,570	2,150	2,232
Other Prepaid Expenses and Receivables
Current Assets Held for Disposition
Prepaid Expenses and Other Receivables
Total Current Assets	24,839	24,468	23,153	23,656	23,802	23,119
Total Current Assets
Net Property, Plant & Equipment	11,504	11,395	10,932	10,658	10,621	10,233
Property and Equipment, at Cost
Less: Accumulated Depreciation and Amortization
Land
Buildings
Equipment
Construction in Progress
Net Intangible Assets	5,598	5,920	6,261	6,647	7,352	7,827
Intangible Assets, Net of Amortization
Goodwill	23,971	23,952	23,359	23,108	23,658	23,308
Goodwill
Long-Term Investments	951	958	907	886	912	877
Investments
Other Long-Term Assets	17,318	17,306	16,836	16,459	8,011	7,653
Deferred Income Taxes and Other Assets
Non-Current Assets Held for Disposition
Total Assets	84,181	83,999	81,448	81,414	74,356	73,017
Total Assets

Liabilities	Sep '25	Jun '25	Mar '25	Dec '24	Sep '24	Jun '24
Accounts Payable	4,123	4,306	4,214	4,195	4,034	4,125
Trade Accounts Payable
Accrued Expenses	7,615	7,206	6,767	6,844	7,045	6,460
Salaries, Wages and Commissions
Other Accrued Liabilities
Short-Term Debt	—	—	—	—	—	—
Short-Term Borrowings
Current Portion of Long-Term Debt	1,345	507	506	1,500	2,154	1,615
Current Portion of Long-Term Debt
Other Current Liabilities	1,499	1,420	1,517	1,618	1,669	1,560
Dividends Payable
Income Taxes Payable
Current Liabilities Held for Disposition
Total Current Liabilities	14,582	13,439	13,004	14,157	14,902	13,760
Total Current Liabilities
Long-Term Debt	11,596	12,930	12,736	12,625	12,825	13,139
Long-Term Debt
Other Long-Term Liabilities	6,739	6,801	6,644	6,731	6,601	6,558
Post-Employment Obligations, Deferred Income Taxes and Other Long-Term Liabilities
Non-Current Liabilities Held for Disposition
Total Long-Term Liabilities	18,335	19,731	19,380	19,356	19,426	19,697
Total Liabilities	32,917	33,170	32,384	33,513	34,328	33,457

Equity	Sep '25	Jun '25	Mar '25	Dec '24	Sep '24	Jun '24
Common Stock	25,412	25,284	25,125	25,153	25,020	24,858
Issued at Stated Capital Amount
Treasury Stock	-16,877	-16,610	-16,612	-16,844	-16,476	-15,759
Common Shares Held in Treasury, at Cost
Accumulated Other Comprehensive Income	-6,684	-6,576	-7,417	-7,906	-7,804	-8,135
Accumulated Other Comprehensive Income
Retained Earnings	49,103	48,467	47,715	47,261	39,056	38,354
Earnings Employed in the Business
Total Common Shareholders' Equity	50,954	50,565	48,811	47,664	39,796	39,318
Total Abbott Shareholders' Investment
Minority Interests and Other	310	264	253	237	232	242
Noncontrolling Interests
Total Shareholders' Equity	51,264	50,829	49,064	47,901	40,028	39,560
Total Shareholders' Investment
Total Liabilities and Shareholders' Equity	84,181	83,999	81,448	81,414	74,356	73,017
Total Liabilities and Shareholders' Investment